Home | Databases | WorldLII | Search | Feedback Edited Legal Collections Data

"CONTENTS" [2019] ELECD 1260; in Figueroa, Pablo; Guerrero, Alejandro (eds), "EU Law of Competition and Trade in the Pharmaceutical Sector" (Edward Elgar Publishing, 2019) v

Book Title: EU Law of Competition and Trade in the Pharmaceutical Sector

Editor(s): Figueroa, Pablo; Guerrero, Alejandro

Publisher: Edward Elgar Publishing

Section Title: CONTENTS

Number of pages: 2

Extract:

CONTENTS




Extended contents vii
List of figures xv
List of tables xvi
List of contributors xvii
Table of cases xix
Table of legislation xxxviii

1 Competition law and pharma: an economic perspective 1
Benoît Durand
2 Reverse payments: an EU and US perspective 35
Frank Maier-Rigaud, Nathan Blalock and Oliver Gannon
3 Article 101 TFEU: horizontal cooperation agreements in the pharmaceutical sector 109
Soledad Blanco Thomas, Lilia Luchianov and Thomas Weck
4 The competitive assessment of IP licensing agreements in the pharmaceutical sector 175
Pierre Moullet
5 Article 102 TFEU: patent filings as an abuse of dominant position after AstraZeneca:
the patent­antitrust interface under a new perspective 219
Francisco Hernández
6 Mergers in the pharmaceutical sector 247
Pablo Figueroa and Alejandro Guerrero
7 Mergers in the medical devices sector 269
Jan Heithecker
8 Antitrust practices in pharmaceutical public procurement 311
Antonio Miño López
9 EU trade law and pharmaceuticals 377
Pascale Hecker
10 The pharmaceutical sector and parallel trade 405
Edurne Navarro Varona and Cristina Caballero Candelario
11 Free movement and competition in the European market for pharmaceuticals 431
Pedro Caro de Sousa
12 IP law and pharmaceuticals: patents and supplementary protection certificates in the
pharmaceutical sector 459
Rais Amils
13 The EU regulatory framework for medicinal products for human use 503
Marc Martens and Nicolas Carbonnelle
14 Antitrust and the pharmaceutical industry in the United States 552
George A. Hay



v
CONTENTS


15 UK competition and trade in the pharma sector 578
Paula ...